The World Health Organisation granted the much-awaited Emergency Use Listing (EUL) to Hyderabad based Bharat Biotech, a move that will allow people inoculated with Covaxin to travel abroad without restrictions.
Covaxin vaccine was also reviewed by WHO’s Strategic Advisory Group of Experts on Immunization (SAGE), and recommended use of this vaccine in two doses, with a dose interval of four weeks, in all age groups 18 and above, it further said.
WHO has so far approved Covid-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio/Serum Institute of India, Johnson & Johnson-Janssen, Moderna, and Sinopharm for emergency use.
However, the approval to Covaxin came after a long wait. Bharat Biotech had submitted its Expression of Interest (EOI) on April 19 and a pre-submission meeting was held in May-June 2021.
Source: https://economictimes.indiatimes.com
.jpg)
No comments:
Post a Comment